✨
AI Summary
- Oren Gilad explains precision oncology and synthetic lethality.
- Aprea develops therapies targeting cancer's genetic vulnerabilities.
- Biomarker-driven development is key for future treatments.
Guests on This Episode
OG
Oren Gilad
1 podcast appearance